Edwards Lifesciences (1EW) Stock Forecast & Price Target
0 Followers
1EW Analyst Ratings
Strong Buy
12Buy1Hold0Sell
Based on 13 analysts giving stock ratings to Edwards Lifesciences in the past 3 months
1EW Stock 12 Month Forecast
Average Price Target
EUR 94.30▲(10.27% Upside)Based on 13 Wall Street analysts offering 12 month price targets for Edwards Lifesciences in the last 3 months. The average price target is EUR 94.30 with a high forecast of EUR 104.09 and a low forecast of EUR 75.62. The average price target represents a 10.27% change from the last price of EUR 85.52.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 104.09
AverageEUR 94.30
LowEUR 75.62
Highest Price TargetHighestEUR 104.09Average Price TargetEUR 94.30Lowest Price TargetLowestEUR 75.62
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Christopher Pasquale | Barclays | EUR 97.86 | buy | 14.43%Upside | Reiterated | 11/04/26 | ||
| Josh Jennings | TD Cowen | EUR 92.52→EUR 104.09 | buy | 21.71%Upside | Reiterated | 11/03/26 | ||
| Richard Newitter | Truist Financial | EUR 100.53 | buy | 17.55%Upside | Upgraded | 11/03/26 | ||
| William Plovanic | Canaccord Genuity | EUR 75.62 | hold | -11.58%Downside | Reiterated | 11/03/26 | ||
| Travis Steed | Bank of America Securities | EUR 88.96 | buy | 4.02%Upside | Reiterated | 11/02/26 | ||
| Kendall Au | RBC Capital | EUR 97.86 | buy | 14.43%Upside | Reiterated | 11/02/26 | ||
| Joanne Wuensch | Citi | EUR 94.30→EUR 97.86 | buy | 14.43%Upside | Reiterated | 11/01/26 | ||
| Mike Kratky | Leerink Partners | EUR 88.96→EUR 89.85 | buy | 5.06%Upside | Reiterated | 10/15/26 | ||
| Marie Thibault | BTIG | EUR 97.86 | buy | 14.43%Upside | Reiterated | 10/09/26 | ||
| Patrick Wood | UBS | EUR 97.86 | buy | 14.43%Upside | Reiterated | 10/07/26 | ||
| Adam Maeder | Piper Sandler | EUR 89.85 | buy | 5.06%Upside | Reiterated | 09/21/26 | ||
| Matthew Taylor | Jefferies | EUR 93.41 | buy | 9.23%Upside | Reiterated | 09/11/26 | ||
| Brandon Vazquez | William Blair | ― | buy | ― | Reiterated | 09/10/26 | ||
| Robbie Marcus | J.P. Morgan | EUR 93.41 | buy | 9.23%Upside | Reiterated | 07/28/26 | ||
| Suraj Kalia | Oppenheimer | ― | hold | ― | Reiterated | 07/24/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Christopher PasqualeBarclays | BuyReiteratedEUR 97.86 | 11/04/26 | 14.43%Upside | ||
| Josh JenningsTD Cowen | BuyReiteratedEUR 92.52→EUR 104.09 | 11/03/26 | 21.71%Upside | ||
| Richard NewitterTruist Financial | BuyUpgradedEUR 100.53 | 11/03/26 | 17.55%Upside | ||
| William PlovanicCanaccord Genuity | HoldReiteratedEUR 75.62 | 11/03/26 | -11.58%Downside | ||
| Travis SteedBank of America Securities | BuyReiteratedEUR 88.96 | 11/02/26 | 4.02%Upside | ||
| Kendall AuRBC Capital | BuyReiteratedEUR 97.86 | 11/02/26 | 14.43%Upside | ||
| Joanne WuenschCiti | BuyReiteratedEUR 94.30→EUR 97.86 | 11/01/26 | 14.43%Upside | ||
| Mike KratkyLeerink Partners | BuyReiteratedEUR 88.96→EUR 89.85 | 10/15/26 | 5.06%Upside | ||
| Marie ThibaultBTIG | BuyReiteratedEUR 97.86 | 10/09/26 | 14.43%Upside | ||
| Patrick WoodUBS | BuyReiteratedEUR 97.86 | 10/07/26 | 14.43%Upside | ||
| Adam MaederPiper Sandler | BuyReiteratedEUR 89.85 | 09/21/26 | 5.06%Upside | ||
| Matthew TaylorJefferies | BuyReiteratedEUR 93.41 | 09/11/26 | 9.23%Upside | ||
| Brandon VazquezWilliam Blair | BuyReiterated | 09/10/26 | ― | ||
| Robbie MarcusJ.P. Morgan | BuyReiteratedEUR 93.41 | 07/28/26 | 9.23%Upside | ||
| Suraj KaliaOppenheimer | HoldReiterated | 07/24/26 | ― |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Edwards Lifesciences
3 Months
Success Rate19/29 ratings generated profit
66%
Average Return
+1.75%
Copying Adam Maeder's trades and holding each position for 3 Months would result in 65.52% of your transactions generating a profit, with an average return of +1.75% per trade.
1 Year
Success Rate12/14 ratings generated profit
86%
Average Return
+5.59%
Copying Travis Steed's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +5.59% per trade.
2 Years
Success Rate12/14 ratings generated profit
86%
Average Return
+9.61%
Copying Travis Steed's trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +9.61% per trade.
1EW Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 39 | 34 | 25 | 17 | 21 |
| Hold | 6 | 7 | 5 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 45 | 41 | 30 | 18 | 22 |
In the current month, 1EW has received 21 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 1EW average Analyst price target in the past 3 months is 94.30.
1EW Financial Forecast
HighEUR 0.69
ConsensusEUR 0.66
LowEUR 0.64
1EW Earnings Forecast
Next quarter’s earnings estimate for 1EW is EUR 0.66 with a range of EUR 0.64 to EUR 0.69. The previous quarter’s EPS was EUR 0.69. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 1.51B
ConsensusEUR 1.49B
LowEUR 1.47B
1EW Sales Forecast
Next quarter’s sales forecast for 1EW is EUR 1.49B with a range of EUR 1.47B to EUR 1.51B. The previous quarter’s sales results were EUR 1.55B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
1EW Stock Forecast FAQ
What is IT:1EW’s average 12-month price target, according to analysts?
Based on analyst ratings, Edwards Lifesciences’s 12-month average price target is €94.30.
What is IT:1EW’s upside potential, based on the analysts’ average price target?
Edwards Lifesciences has 10.27% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Edwards Lifesciences a Buy, Sell or Hold?
Edwards Lifesciences has a consensus rating of Strong Buy, which is based on 12 buy ratings, 1 hold ratings and 0 sell ratings.
What is Edwards Lifesciences’s share price target?
The average share price target for Edwards Lifesciences is €94.30. This is based on 13 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €104.09, and the lowest forecast is €75.62. The average share price target represents a 10.27% increase from the current price of €85.52.
What do analysts say about Edwards Lifesciences?
Edwards Lifesciences’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Street analysts.
How can I buy shares of Edwards Lifesciences?
To buy shares of IT:1EW, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
